AI assistant
Xylem Inc. — Director's Dealing 2011
Nov 3, 2011
30109_dirs_2011-11-03_6ce2cb07-7fe8-4f7d-9beb-810c2d2c4d26.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Xylem Inc. (XYL)
CIK: 0001524472
Period of Report: 2011-11-01
Reporting Person: CRAWFORD CURTIS J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-11-01 | Common Stock | A | 3550 | $0.00 | Acquired | 39281 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-11-01 | Stock Option (Right to Buy) | $19.40 | A | 3560 | Acquired | 2012-05-07 | Common Stock (3560) | Direct |
| 2011-11-01 | Stock Option (Right to Buy) | $17.35 | A | 2420 | Acquired | 2013-01-04 | Common Stock (2420) | Direct |
| 2011-11-01 | Stock Option (Right to Buy) | $21.03 | A | 2480 | Acquired | 2014-02-02 | Common Stock (2480) | Direct |
| 2011-11-01 | Stock Option (Right to Buy) | $25.53 | A | 2140 | Acquired | 2012-03-08 | Common Stock (2140) | Direct |
| 2011-11-01 | Stock Option (Right to Buy) | $29.57 | A | 3040 | Acquired | 2013-03-06 | Common Stock (3040) | Direct |
| 2011-11-01 | Stock Option (Right to Buy) | $32.56 | A | 2700 | Acquired | 2014-03-07 | Common Stock (2700) | Direct |
| 2011-11-01 | Stock Option (Right to Buy) | $29.81 | A | 2960 | Acquired | 2015-03-10 | Common Stock (2960) | Direct |
| 2011-11-01 | Stock Option (Right to Buy) | $18.63 | A | 3970 | Acquired | 2016-03-05 | Common Stock (3970) | Direct |
| 2011-11-01 | Stock Option (Right to Buy) | $30.03 | A | 2860 | Acquired | 2020-03-05 | Common Stock (2860) | Direct |
Footnotes
F1: The total amount of securities beneficially owned following the reported transactions includes securities that were received in connection with the spin-off of Xylem Inc. from ITT Corporation in a transaction that was exempt from reporting under Rule 16a-9 under the Securities Exchange Act of 1934.
F2: These options are fully vested and exercisable.
F3: 2,647 options are vested and exercisable and the remaining 1,323 options will vest on March 5, 2012.
F4: 954 options are vested and exercisable and the remainder will vest in two equal annual installments beginning on March 5, 2012.